For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading.
But efforts to detect cancers early have led to a quandary. Current screening tests too often fail to find high-risk cancers while at the same time raising too many alarms about essentially harmless growths. The technologies used for early detection can’t reliably distinguish aggressive, life-threatening abnormalities from those that are unlikely to ever become dangerous.
Sadik Esener, Ph.D.
Thursday, Nov. 16, 2017 at 7 p.m.
Register to attend
At the OHSU Knight Cancer Institute, Sadik Esener, Ph.D., is building a multidisciplinary team seeking to overcome this dilemma. In a Marquam Hill Lecture in November, he’ll explain how Knight Cancer Institute scientists are probing cancer’s initiating events and early malignant changes, and applying this knowledge to develop low-cost screening tests, determine which cancers to vigorously treat, and direct precision therapies to minimize toxicity.
Esener is the Wendt Family Chair professor of biomedical engineering in the OHSU School of Medicine and director of CEDAR, the Knight Cancer Institute’s Early Detection Advanced Research Center.